CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Thermo Fisher Scientific Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Thermo Fisher Scientific Inc
168 Third Avenue
Phone: (781) 622-1000p:781 622-1000 WALTHAM, MA  02451  United States Ticker: TMOTMO
Business Summary
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Industries
SIC Code Description
3829 Measuring and controlling devices, not elsewhere classified
3845 Electromedical and electrotherapeutic apparatus
8734 Testing laboratories
8731 Commercial physical and biological research
7372 Prepackaged software
3823 Industrial instruments for measurement, display, and control of processes
2835 In vitro and in vivo diagnostic substances
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Marc N.Casper 55 1/1/2020 12/1/2001
Chief Financial Officer, Senior Vice President StephenWilliamson 56 8/1/2015 8/1/2015
Chief Operating Officer, Executive Vice President MichelLagarde 49 1/1/2022 8/1/2017
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Perbio Science AB
FISHER SCIENTIFIC IRELAND LIMITED 25/28 NORTH WALL QUAY DUBLIN 1DUBLIND01H104IRELAND IE
THERMO FISHER SCIENTIFIC (PN1) UK LIMITED 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM UK
117 additional Subsidiary records available in full report.

Business Names
Business Name
0972792 B.C. LTD
236 Perinton Parkway, LLC
27 Forge Parkway LLC
1116 additional Business Names available in full report.

General Information
Number of Employees: 122,000 (As of 12/31/2023)
Outstanding Shares: 381,713,867 (As of 3/25/2024)
Shareholders: 2,337
Stock Exchange: NYSE
Federal Tax Id: 042209186
Fax Number: (781) 622-1207
Email Address: investorrelations@thermo.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024